Session

Functional outcome in urinary reconstruction

Poster Session 71

  • Location:
    Room 14c (ICM, Level 1)
  • Chairs:
     S. Deger, Ostfildern (DE)
     M. Gallucci, Rome (IT)
     I. Moncada, Madrid (ES)
  • Aims and objectives of this session

    Overview of functional outcome of reconstructive urology.

  • Poster viewing of 20 minutes. Presentations will take place on stage. Standard presentations are 2 minutes in length, followed by 2 minutes for discussion.
895
The results of 21 ureteral substitutions with appendix

By: Komyakov B., Guliev B., Ochelenko V.A.

Institutes: North-West State Medical University, Dept. of Urology, Saint-Petersburg, Russia

896
Laparoscopic ileal ureteral substitution

By: Komyakov B., Guliev B., Ochelenko V.

Institutes: North-West State Medical University, Dept. of Urology, Saint-Petersburg, Russia

897
Continent urinary diversion to rectal bladder constructed by a modified Duhamel’s technique in children

By: Fahmy M.A.B.

Institutes: Al Azhar, Cairo, Egypt

898
The medium term outcomes of stoma formation for patients undergoing conduit diversion for functional aetiology: 5 Year follow-up

By: Kose O., Solomon E., Pakzad M., Shah J.R., Hamid R., Greenwell T.J., Ockrim J.

Institutes: University College London Hospitals, Dept. of Urology, London, United Kingdom

899
Benign uretero-ileal strictures after urinary diversion: Endo-urological treatment versus open surgical revision

By: Fransen Van De Putte E.1, De Wall L.2, Heldeweg E.2, Leijte J.1, Bex A.1, Van Der Poel H.1, Van Rhijn B.1, Horenblas S.1, Hendricksen K.1

Institutes: 1The Netherlands Cancer Institute – Antoni Van Leeuwenhoek Hospital, Dept. of Urology, Amsterdam, The Netherlands, 2Onze Lieve Vrouwe Gasthuis – West, Dept. of Urology, Amsterdam, The Netherlands

900
Pelvic fistulas post-radiotherapy: Conservative surgical management is doomed to fail

By: Schudel H., Thalmann G.N., Nguyen D.P.

Institutes: University Hospital Berne, Dept. of Urology, Berne, Switzerland

901
Safety of vaginal mesh - a population based study

By: Forde J.1, Chughtai B.1, Barber M.2, Mao J.3, Te A.1, Sedrakyan A.3

Institutes: 1Weill Cornell Medical College/New York Presbyterian Hospital, Dept. of Urology, New York, United States of America, 2Cleveland Clinic, Obstetrics, Gynecology, and Women’s Health Institute, Cleveland, United States of America, 3Weill Cornell Medical College/New York Presbyterian Hospital, Dept. of Healthcare Policy and Research, New York, United States of America

902
Is there a difference in outcome between early versus delayed removal of suburethral mid-urethral sling?

By: Aggarwal H., Foster J., Singla N., Alhalabi F., Lemack G., Zimmern P.

Institutes: Ut Southwestern Medical Center, Dept. of Urology, Dallas, United States of America

903
Residual pelvic pain/dyspareunia management after synthetic vaginal mesh and/or sling removal

By: Abraham A.1, Scott K.2, Zimmern P.1

Institutes: 1UT Southwestern Medical Center, Dept. of Urology, Dallas, United States of America, 2UT Southwestern Medical Center, Dept. of PMR, Dallas, United States of America

904
Successful treatment of vesico-vaginal fistula: A single-centre 35 years experience on 106 consecutive cases

By: Mancini M., Righetto M.L., Dal Moro F., Calpista A., Zattoni F.

Institutes: Urological Clinic, University of Padua, Dept. of Surgical and Oncological Sciences, Padua, Italy

905
Factors associated with success or failure in VVF repair

By: Beardmore-Gray A., Pakzad M., Hamid R., Ockrim J.L., Greenwell T.

Institutes: University College London Hospital, Dept. of Urology, London, United Kingdom

906
Risk of prolapse recurrence after native tissue anterior prolapse repair with intermediate to long-term follow-up

By: Lavelle R.1, Christie A.2, Alhalabi F.1, Zimmern P.1

Institutes: 1UT Southwestern Medical Center, Dept. of Urology, Dallas, United States of America, 2UT Southwestern Medical Center, Dept. of Biostatistics, Dallas, United States of America

908
Urinary tract reconstruction outcomes following total pelvic exenteration for locally advanced and recurrent rectal cancer

By: Khan O.1, Patsouras D.2, Thuairaja R.1, Khan M.1, Schizas A.2, George M.2, Sahai A.1

Institutes: 1Guy’s and St Thomas’ Nhs Foundation Trust & King’s College London, Dept. of Urology, London, United Kingdom, 2Guy’s and St Thomas’ Nhs Foundation Trust & King’s College London, Dept. of Colorectal Surgery, London, United Kingdom

909
Genetically modified human muscle precursor cells overexpressing PGC-1α support early myofiber formation for bioengineering of slow twitch sphincter muscle

By: Haralampieva D.1, Salemi S.1, Dinulovic I.2, Sulser T.1, Ametamey S.M.3, Handschin C.2, Eberli D.1

Institutes: 1University Hospital Zurich, Dept. of Urology, Zürich, Switzerland, 2University of Basel, Biocenter, Zürich, Switzerland, 3ETH Zurich, Institute of Pharmaceutical Sciences Biocenter, Zürich, Switzerland